产品图片
货号/SKU
HM-412D
货号/规格
EA
库存与交货期
3-8周
人民币价格
14000
试剂海关审批
A/B级风险物质只能直接使用人购买并持有实验室有效资质,其它询客服确认
国外采购
支持/部分限制一年内购买数量
厂牌
BEI Resources(ATCC)
产品基础信息
生物安全等级建议分类:美国、1
产品描述信息
HM-412D?? Genomic DNA from Bifidobacterium breve, Strain EX336960VC19(Nucleic Acids)|Bifidobacterium breve|Genomic DNA from Bifidobacterium breve, Strain EX336960VC19|-20°C or colder|GA BuckAcknowledgment for publications should read "The following reagent was obtained through BEI Resources, NIAID, NIH as part of the Human Microbiome Project: Genomic DNA from Bifidobacterium breve, Strain EX336960VC19, HM-412D."|Quantity limit per order for this item is 1. This item can be ordered twice a year. Orders over this limit will be sent to NIAID for approval before shipment.
Genomic DNA was obtained from a preparation of Bifidobacterium breve (B. breve), strain EX336960VC19.
B. breve, strain EX336960VC19 was isolated from a human mid-vaginal wall in March 2010 in Richmond, Virginia. B. breve, strain EX336960VC19 (HMP 9667) is a reference genome for The Human Microbiome Project (HMP). HMP is an initiative to identify and characterize human microbial flora. B. breve, strain EX336960VC19 is currently being sequenced at the Virginia Commonwealth University. Please refer to the B. breve, strain EX336960VC19 NCBI BioProject for sequence status updates.
HM-412D has been qualified for PCR applications by amplification of approximately 1500 bp of the 16S ribosomal RNA gene.
Each vial contains 0.7 to 1.5 ?g of bacterial genomic DNA in TE buffer (10 mM Tris-HCl and 1 mM EDTA, pH ~ 8.0).
Genomic DNA was obtained from a preparation of Bifidobacterium breve (B. breve), strain EX336960VC19.
B. breve, strain EX336960VC19 was isolated from a human mid-vaginal wall in March 2010 in Richmond, Virginia. B. breve, strain EX336960VC19 (HMP 9667) is a reference genome for The Human Microbiome Project (HMP). HMP is an initiative to identify and characterize human microbial flora. B. breve, strain EX336960VC19 is currently being sequenced at the Virginia Commonwealth University. Please refer to the B. breve, strain EX336960VC19 NCBI BioProject for sequence status updates.
HM-412D has been qualified for PCR applications by amplification of approximately 1500 bp of the 16S ribosomal RNA gene.
Each vial contains 0.7 to 1.5 ?g of bacterial genomic DNA in TE buffer (10 mM Tris-HCl and 1 mM EDTA, pH ~ 8.0).
主要内容
此项目的每个订单数量限制为1.此项目每年可订购两次.此限制的订单将在发货前发送到NIAID进行批准. 基因组DNA是从制备中获得的双歧杆菌BREVE ( B. breve ),应变EX336960VC19. b. Breve ,在2010年3月在弗吉尼亚里士满的2010年3月中分离出菌株EX336960VC19. b. Breve ,Struite ex336960vc19( hmp 9667 )是一个参考基因组对于人类微生物群项目(HMP). HMP是一项识别和表征人微生物菌群的倡议. b. Breve ,应变EX336960VC19目前正在弗吉尼亚英联邦大学.请参考 b. breve ,strut ex336960vc19 ncbi bioproject 用于序列状态更新. HM-412D已通过扩增16S核糖体RNA基因的约1500bp授予PCR应用. 每个小瓶在Te缓冲液中含有0.7-1.5μg的细菌基因组DNA(10 mm Tris-HCl和1 mm EDTA,pH?8.0).
厂牌介绍
BEI Resources 由美国国家过敏和传染病研究所 ( NIAID )成立,旨在为研究 A、B 和 C 类优先病原体、新兴传染病病原体、非病原微生物和其他相关微生物材料提供试剂、工具和信息到研究界。BEI Resources 获取、验证和生产科学家进行基础研究和开发改进的诊断测试、疫苗和疗法所需的试剂。通过将这些功能集中在 BEI Resources 中,可以监控科学界对这些材料的访问和使用,并确保试剂的质量控制。
除了为传染病界提供材料外,BEI Resources 还鼓励和支持研究人员和机构的材料存放。使用 BEI Resources存放材料对研究人员和研究社区有许多优势,包括安全存储、社区访问和分发;同时保护存款人的知识产权。只要有需要,BEI 资源库将作为研究人员的资源进行维护。您在 BEI Resources 的存款是一项有助于未来研究的长期投资。
BEI Resources 自 2003 年起由美国典型培养物保藏中心 (ATCC) 根据合同管理。2016 年 5 月, ATCC获得了一份为期七年的继续管理 BEI Resources的合同。合同范围已扩大到更全面的研究目录材料,包括由其他政府支持的研究项目存放的材料,将提供给生物防御和新兴传染病科学界。真菌、寄生虫、载体和其他相关材料已添加到现有的细菌、病毒和毒素试剂中,涵盖 NIAID A、B 和 C 类优先病原体和 NIAID 指定的新发传染病病原体和生物。
品牌标识
可能感兴趣的内容
2022-04-01
2022-04-01
2021-12-21
2024-09-22
2022-04-01
2024-10-20
2021-12-21
2022-03-31
2024-05-19
2022-04-01
2021-12-13
2024-06-25
2022-04-01